News Medical on MSN
TB and HIV treatments are not enough for a full recovery
Texas Biomed researchers find that existing treatments control TB and HIV, but the immune system does not revert to normal, ...
A novel iPSC-derived lung-on-chip model mimics human alveolar tissue, revealing macrophage-driven tuberculosis responses.
UCB Canada Inc. is pleased to announce Health Canada has granted a Notice of Compliance (NOC) for PrBIMZELX® (bimekizumab injection) indicated for the treatment of adult patients with moderate to ...
Researchers at the Indian Institute of Science (IISc), with collaborators from the Institute of Mathematical Sciences (IMSc), ...
Systemic therapy for sarcoidosis is reserved for organ-threatening disease, and laryngeal involvement necessitates treatment ...
News-Medical.Net on MSN
Study reveals how tuberculosis exploits immune defenses to promote infection
Scientists have made a discovery that helps explain why humans and animals are so susceptible to contracting tuberculosis(TB) ...
News-Medical.Net on MSN
Key protein in the tuberculosis bacterium helps protect itself from foreign DNA
Researchers at the Indian Institute of Science (IISc), with collaborators from the Institute of Mathematical Sciences (IMSc), ...
A sugar on mycobacteria binds to the immune receptor dectin-1 on host macrophages, helping the bacteria survive and driving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback